http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-200302104-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b8be6a6c990669567cc455d32b00535e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0264ab149dd139d522f7f14b1a3ea9e2 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7024 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7024 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H3-06 |
| filingDate | 2003-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb6992b518420a3933dfb11f3ec182f0 |
| publicationDate | 2003-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-200302104-A |
| titleOfInvention | A pharmaceutical composition comprising SANORG34006 for treatment and secondary prophylaxis of venous thromboemolic events in patients with deep venous thrombosis |
| abstract | The invention relates to a pharmaceutical composition comprising 2.5 mg of the pentasaccharide methyl O-( 2, 3, 4-tri-O-methyl-6-O-sulfo-α-D- glucopyranosyl)-(1 arrow right 4)-O-(2, 3-di-O-methyl-β-D-glucopyranosyl uronic acid)-(1 arrow right 4)-O-( 2, 3, 6-tri-O-sulfo-α-D-glucopyranosyl)-(1 arrow right 4)-O-( 2, 3-di-O-methyl-α-L-idopyranosyl uronic acid)-(1 arrow right 4)-2, 3, 6-tri-O-sulfo-α-D-glucopyranoside or a pharmaceutically acceptable salt thereof for use in therapy, in particular for the treatment and/or secondary prophylaxis of venous thromboembolic events in patients with deep venous thrombosis. |
| priorityDate | 2002-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 30.